Shots:
- Terumo has entered into a definitive agreement to acquire OrganOx, expanding to organ transplantation-related sector
- As per the deal, Terumo will acquire all outstanding shares of OrganOx for ~$1.5B, making it a wholly owned subsidiary upon deal completion
- Acquisition aims to leverage Terumo’s medical device expertise with OrganOx’s Normothermic Machine Perfusion (NMP) technology to advance global organ preservation solutions. OrganOx is also developing a kidney NMP device, with commercialization expected by 2030
Ref: Terumo | Image: OrganOx | Press Release
Related News:- Syndicate of Global Investors to Acquire HistoSonics for $2.25B
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
